Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

about

Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

P2860

Q47626451-61647E6C-7646-44A8-9B1D-61F6DD02E200

P2860

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

Item

http://www.wikidata.org/entity/Q48113077

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@en

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@nl

type

Item

label

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@en

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@nl

prefLabel

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@en

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@nl

P1476

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

@en

P2093

Alexander C Bunck

http://www.w3.org/2001/XMLSchema#string

Carsten Kobe

http://www.w3.org/2001/XMLSchema#string

Guido Michels

http://www.w3.org/2001/XMLSchema#string

Henrik Ten Freyhaus

http://www.w3.org/2001/XMLSchema#string

Roman Pfister

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis.

Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.

Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Bone scintigraphy with99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis

P2888

s00392-017-1092-3

P304

471-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00392-017-1092-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Kristina Dahlem

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28303323

http://www.w3.org/2001/XMLSchema#string

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

about

P2860

P2860

Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698